RxSight, Inc.
RXST- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001111485
In the last 90 days, RxSight, Inc. insiders filed 0 open-market purchases and 4 sales; 151 institutions reported holding it in 13F filings for Q2 2026, worth $199.8M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding RxSight, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 115 | 128 | +13 |
| Shares | 22.1M | 25.7M | +3.63M (+16.4%) |
| Value | $637.0M | $718.1M | +$81.1M (+12.7%) |
New holders (28)
Institutions that held RxSight, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (15)
Institutions that held RxSight, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jane Street Group, LLC | 71,680 | $2.06M |
| HRT Financial LP | 46,044 | $1.33M |
| Renaissance Technologies LLC | 38,900 | $1.12M |
| Fred Alger Management, LLC | 30,491 | $878.1K |
| Temasek Holdings (Private) Ltd | 21,694 | $624.8K |
| Boston Partners | 20,436 | $588.6K |
| Occudo Quantitative Strategies LP | 17,544 | $505.3K |
| Walleye Capital LLC | 15,679 | $451.6K |
| Bank of Montreal | 15,270 | $441.9K |
| Zacks Investment Management | 13,830 | $398.3K |
| Graham Capital Management, L.P. | 10,012 | $288.3K |
| Verition Fund Management LLC | 9,431 | $271.6K |
| Qube Research & Technologies Ltd | 7,297 | $210.2K |
| Counterpoint Mutual Funds LLC | 4,543 | $130.8K |
| FNY Investment Advisers, LLC | 4,400 | $126.0K |